Molecular analysis and immunological characterization of a founder mutation causing ARPC1B deficiency

Area of Science:

• Immunology
• Genetics
• Cell Biology

Background:

• Actin-Related Protein Complex 1B (ARPC1B) is a key component of the ARP2/3 complex, regulating actin polymerization.
• ARPC1B is primarily expressed in hematopoietic cells and its deficiency causes combined immunodeficiency (CID) with various symptoms.

Purpose of the Study:

• To characterize the disease-causing ARPC1B variant c.899_944del (p.E300Gfs*7) found in an indigenous American population.
• To investigate the molecular and immunological consequences of ARPC1B deficiency.

Main Methods:

• Genetic sequencing to identify and characterize the ARPC1B variant.
• Mass cytometry (CyTOF) to analyze immune cell population frequencies in the patient.
• Protein expression analysis to confirm ARPC1B deficiency.

Main Results:

• The c.899_944del variant leads to a complete deficiency of ARPC1B protein expression.
• ARPC1B deficiency was associated with reduced frequencies of class-switched memory B cells, indicating impaired class switching.
• Significant reductions in CD4+, CD8+, and γδ T cell populations were observed, suggesting a role in T cell development.

Conclusions:

• The study elucidates the impact of the specific ARPC1B mutation c.899_944del on immune function.
• ARPC1B is essential for normal B cell class switching and T cell development.
• This research deepens the understanding of ARPC1B's role in maintaining a healthy immune system.